U.S. flag

An official website of the United States government

NM_002693.3(POLG):c.2584G>A (p.Ala862Thr) AND POLG-Related Spectrum Disorders

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 15, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003330728.1

Allele description [Variation Report for NM_002693.3(POLG):c.2584G>A (p.Ala862Thr)]

NM_002693.3(POLG):c.2584G>A (p.Ala862Thr)

Genes:
POLG:DNA polymerase gamma, catalytic subunit [Gene - OMIM - HGNC]
POLGARF:POLG alternative reading frame [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q26.1
Genomic location:
Preferred name:
NM_002693.3(POLG):c.2584G>A (p.Ala862Thr)
HGVS:
  • NC_000015.10:g.89321750C>T
  • NG_008218.2:g.18046G>A
  • NM_001126131.2:c.2584G>A
  • NM_002693.3:c.2584G>AMANE SELECT
  • NP_001119603.1:p.Ala862Thr
  • NP_002684.1:p.Ala862Thr
  • NP_002684.1:p.Ala862Thr
  • LRG_765t1:c.2584G>A
  • LRG_765:g.18046G>A
  • LRG_765p1:p.Ala862Thr
  • NC_000015.9:g.89864981C>T
  • NM_002693.2:c.2584G>A
Protein change:
A862T
Links:
dbSNP: rs778429780
NCBI 1000 Genomes Browser:
rs778429780
Molecular consequence:
  • NM_001126131.2:c.2584G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002693.3:c.2584G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
POLG-Related Spectrum Disorders
Identifiers:
MedGen: C4763519

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004039532Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Aug 15, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.

Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, Milone M, Cohen BH, Wical B, Ganesh J, Basinger AA, Burton BK, Swoboda K, Gilbert DL, Vanderver A, Saneto RP, Maranda B, Arnold G, Abdenur JE, Waters PJ, Copeland WC.

Hum Mutat. 2008 Sep;29(9):E150-72. doi: 10.1002/humu.20824.

PubMed [citation]
PMID:
18546365
PMCID:
PMC2891192

A variable neurodegenerative phenotype with polymerase gamma mutation.

Stricker S, PrĂ¼ss H, Horvath R, Baruffini E, Lodi T, Siebert E, Endres M, Zschenderlein R, Meisel A.

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1181-2. doi: 10.1136/jnnp.2008.166066. No abstract available.

PubMed [citation]
PMID:
19762913
See all PubMed Citations (4)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004039532.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: POLG c.2584G>A (p.Ala862Thr) results in a non-conservative amino acid change located in the palm domain (IPR047580) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251356 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2584G>A has been reported in the literature in multiple compound heterozygous individuals affected with POLG-Related Spectrum Disorders (e.g., Wong_2008, Stricker_2009, Ferreira_2011, Lax_2012). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant was unable to complement a null MIP1 (the yeast ortholog of POLG) mutant or restore mitochondrial respiration in yeast (e.g., Stricker_2009). The following publications have been ascertained in the context of this evaluation (PMID: 21550804, 22189570, 19762913, 18546365). Three submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 23, 2024